These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27029593)

  • 21. Evidence-based point-of-care diagnostics: current status and emerging technologies.
    Chan CP; Mak WC; Cheung KY; Sin KK; Yu CM; Rainer TH; Renneberg R
    Annu Rev Anal Chem (Palo Alto Calif); 2013; 6():191-211. PubMed ID: 23527548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connectivity of rapid-testing diagnostics and surveillance of infectious diseases.
    Ming D; Rawson T; Sangkaew S; Rodriguez-Manzano J; Georgiou P; Holmes A
    Bull World Health Organ; 2019 Mar; 97(3):242-244. PubMed ID: 30992638
    [No Abstract]   [Full Text] [Related]  

  • 23. Economic evaluations of point of care testing strategies for active tuberculosis.
    Zwerling A; Dowdy D
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):313-25. PubMed ID: 23763529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings.
    Kosack CS
    Clin Chem Lab Med; 2012 Jul; 50(7):1221-7. PubMed ID: 23024983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the laboratory in a Chlamydia control programme in a developing country.
    Peeling RW; Oyelese AO; Brunham RC; Achola JO; Ronald AR
    East Afr Med J; 1992 Sep; 69(9):508-14. PubMed ID: 1286634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost-effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care.
    Hendriksen JM; Geersing GJ; van Voorthuizen SC; Oudega R; Ten Cate-Hoek AJ; Joore MA; Moons KG; Koffijberg H
    Expert Rev Mol Diagn; 2015 Jan; 15(1):125-36. PubMed ID: 25537569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing needs, opportunities and constraints for the 21st century microbiology laboratory.
    Van Eldere J
    Clin Microbiol Infect; 2005 Apr; 11 Suppl 1():15-8. PubMed ID: 15816102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid diagnostic tests for infectious diseases in the emergency department.
    Bouzid D; Zanella MC; Kerneis S; Visseaux B; May L; Schrenzel J; Cattoir V
    Clin Microbiol Infect; 2021 Feb; 27(2):182-191. PubMed ID: 32120036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis.
    Schito M; Peter TF; Cavanaugh S; Piatek AS; Young GJ; Alexander H; Coggin W; Domingo GJ; Ellenberger D; Ermantraut E; Jani IV; Katamba A; Palamountain KM; Essajee S; Dowdy DW
    J Infect Dis; 2012 May; 205 Suppl 2(Suppl 2):S169-80. PubMed ID: 22457286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostics in a digital age: an opportunity to strengthen health systems and improve health outcomes.
    Peeling RW
    Int Health; 2015 Nov; 7(6):384-9. PubMed ID: 26553825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Laboratory Tools for Emerging Bacterial Challenges.
    Fournier PE; Drancourt M; Raoult D
    Clin Infect Dis; 2017 Aug; 65(suppl_1):S39-S49. PubMed ID: 28859351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States.
    Weber NC; Klepser ME; Akers JM; Klepser DG; Adams AJ
    Expert Rev Mol Diagn; 2016; 16(2):253-64. PubMed ID: 26560318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point-of-care versus central laboratory testing: an economic analysis in an academic medical center.
    Tsai WW; Nash DB; Seamonds B; Weir GJ
    Clin Ther; 1994; 16(5):898-910; discussion 854. PubMed ID: 7859247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative detection of enterovirus RNA in cerebrospinal fluid: GeneXpert system vs. real-time RT-PCR assay.
    Ninove L; Nougairede A; Gazin C; Zandotti C; Drancourt M; de Lamballerie X; Charrel RN
    Clin Microbiol Infect; 2011 Dec; 17(12):1890-4. PubMed ID: 21848972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care.
    Peterson LR; Hamilton JD; Baron EJ; Tompkins LS; Miller JM; Wilfert CM; Tenover FC; Thomson RB
    Clin Infect Dis; 2001 Feb; 32(4):605-11. PubMed ID: 11181125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Useful clinical tests for early diagnosis of infectious diseases].
    Morisawa Y
    Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2562-5. PubMed ID: 16419598
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence-based point-of-care tests and device designs for disaster preparedness.
    Brock TK; Mecozzi DM; Sumner S; Kost GJ
    Am J Disaster Med; 2010; 5(5):285-94. PubMed ID: 21162410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point-of-Care Testing in Microbiology.
    Samuel L
    Clin Lab Med; 2020 Dec; 40(4):483-494. PubMed ID: 33121617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Powering point-of-care diagnostic devices.
    Choi S
    Biotechnol Adv; 2016; 34(3):321-30. PubMed ID: 26631766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in clinical practice and patient disposition following the introduction of point-of-care testing in a rural hospital.
    Blattner K; Nixon G; Dovey S; Jaye C; Wigglesworth J
    Health Policy; 2010 Jun; 96(1):7-12. PubMed ID: 20034696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.